Skip to main content
. 2005 Apr;79(8):4793–4805. doi: 10.1128/JVI.79.8.4793-4805.2005

TABLE 1.

Summary of Ebola virus GP1 substitution mutants

GP1 Protein expression Viral incorporation Infectivity (%) Classa Note
wt ++++ ++++ 100 Full length sequenced
M1 (D47A/D49A/K50A) ++++ ++++ 17 IV Full length sequenced
M2 (R54A/D55A/K56A) ++++ +++ 1 III Full length sequenced
M6 (K84A/R85A) + + 0 II Full length sequenced
M10 (E103A/E106A) + + 0 II Full length sequenced
M11 (E112A/K114A/K115A) ++++ +++ 10 IV Full length sequenced
M12 (D117A/E120A) +++ ++ 17 III Full length sequenced
M13 (D127A/R130A) ++++ ++++ 71 I
M14 (R134A/R136A) ++++ ++ 59 III
M15 (H139A/K140A) + + 1 II Full length sequenced
M17 (H154A/K155A) + + 1 II Full length sequenced
M18 (D163A/R164A) ++++ +++ 58 I
M21 (K190A/K191A) ++++ ++++ 44 I
M22 (R200A/E201A) ++++ ++++ 77 I
M23 (E207A/D208A) ++++ ++++ 75 I
M25 (E235A/D237A) ++++ ++++ 54 I
L43A ++++ +++ 45 III
D47A ++++ ++++ 53 I
D49A ++++ ++++ 55 I
K50A ++++ ++++ 89 I
L51A ++++ +++ 21 III
R54A ++++ ++++ 50 I
D55A ++++ ++++ 13 IV Full length sequenced
D55E ++++ ++++ 111 I
D55K ++++ ++++ 89 I
K56A ++++ ++++ 46 I
L57A ++++ +++ 2 IV Full length sequenced
L57I ++++ ++++ 7 IV
L57F ++++ ++++ 5 IV
L57K ++++ ++++ 5 IV
Q62A ++++ ++++ 195 I
L63A ++++ ++++ 14 IV
L63I ++++ ++++ 78 I
L63F +++ ++ 2 II
L63K ++ + 0 II
M3 (R64A) ++++ ++++ 0 IV Full length sequenced
R64K ++++ ++++ 120 I
R64E ++++ +++ 0 IV
L68A ++ +++ 3 II
N69A ++++ ++++ 98 I
L70A ++++ ++++ 95 I
M4 (E74A) +++ + 2 III Full length sequenced
M5 (D78A) ++++ ++++ 115 I
K84A ++++ ++++ 94 I
R85A + + 0 II Full length sequenced
W86A + ++ 8 II
F88A ++++ ++++ 1 IV Full length sequenced
F88I ++++ ++++ 104 I
F88E ++++ ++ 0 III
M7 (R89A) +++ +++ 59 I
M8 (K95A) ++++ ++++ 8 IV Full length sequenced, second mutation V48I
K95R ++++ +++ 74 I
K95E ++++ ++ 26 III
Y99A ++ + 3 II
M9 (E100A) ++++ ++++ 48 I
E103A + + 0 II Full length sequenced
W104A ++++ ++++ 92 I
E106A ++++ ++++ 87 I
N107A ++++ ++++ 79 I
Y109A + + 9 II
N110A ++++ ++++ 183 I
L111A ++++ + 2 III
E112A ++++ ++++ 67 I
I113A ++++ ++ 25 III
K114A ++++ ++++ 53 I
K115A ++++ ++++ 56 I
D117A +++ + 17 III
E120A ++++ ++ 35 III
L122A ++++ ++ 4 III Full length sequenced
F132A ++++ + 35 III
Y137A ++++ + 75 III Full length sequenced
H139A + + 2 II Full length sequenced
K140A ++++ ++++ 74 I
M16 (D150A) ++++ ++++ 135 I
F153A ++++ ++ 31 III
H154A + + 0 II Full length sequenced
K155A ++++ ++++ 61 I
F159A ++ ++ 1 II
L161A ++ + 1 II
Y162A ++ + 2 II
L165A ++++ ++++ 55 I
I170A ++++ ++++ 16 IV Full length sequenced
I170F ++++ + 45 III
I170E ++++ + 0 III
Y171A + ++ 1 II
M19 (R172A) ++++ ++++ 55 I
F176A + + 0 II
M20 (E178A) + + 0 II Full length sequenced
F183A ++ + 0 II
L184A ++++ +++ 27 III
I185A ++++ +++ 23 III Full length sequenced
L186A ++++ ++++ 66 I
F193A ++++ ++++ 79 I
F194A ++++ ++++ 67 I
N204A ++++ ++++ 74 I
G212A ++++ ++++ 73 I
Y213A ++++ ++++ 75 I
Y214A ++++ ++++ 69 I
I218A +++ + 43 III
Y220A +++ + 32 III
F225A +++ + 58 III
M24 (E229A) ++++ ++++ 61 I
Y232A ++++ ++++ 82 I
L233A ++++ ++++ 82 I
F234A ++++ ++++ 98 I
Y241A ++++ ++++ 81 I
L244A ++++ ++++ 72 I
M26 (E245A) ++++ ++++ 55 I
F248A ++++ ++++ 105 I
Q251A ++++ ++++ 83 I
F252A ++++ ++++ 74 I
L253A ++++ ++++ 85 I
Q255A ++++ ++++ 101 I
L256A ++++ ++++ 99 I
N257A ++++ ++++ 83 I
M27 (E258A) ++++ ++++ 101 I
I260A ++++ ++++ 110 I
Y261A ++++ ++++ 111 I
N268A ++++ ++++ 91 I
L273A ++++ ++++ 85 I
W275A ++++ ++++ 109 I
a

Class I, no major defect in protein expression or processing, virion incorporation, or viral entry (wild-type phenotype); class II, defect in protein expression or processing; class III, defect in virion incorporation; class IV, defect in viral entry.